The pioneering life science REIT posts its fifth consecutive quarterly loss while accelerating asset sales to shore up balance sheet Alexandria Real Estate...
ByThe RegistryJanuary 28, 2026Quarterly loss and major asset write-downs signal ongoing challenges for pioneering life science REIT Alexandria Real Estate Equities reported its fourth consecutive quarterly...
ByThe RegistryOctober 28, 2025Alexandria Real Estate Equities reported a net loss of $0.64 per share for Q2 2025, marking its third consecutive quarterly loss amid declining...
ByThe RegistryJuly 21, 2025Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science...
ByThe RegistryMay 1, 2025
Signup for news and special announcements!
You have successfully joined our subscriber list.